Mammalian NDR protein kinases: From regulation to a role in centrosome duplication

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1784, Issue 1, 2008, Pages 3-15

  Hergovich, Alexander ^a   Cornils, Hauke ^a   Hemmings, Brian A ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

Author keywords

Activation mechanism; Cellular transformation; Centriole duplication; MOB binding; NDR LATS protein kinase; Subcellular localization; Tumour suppressor

Indexed keywords

PROTEIN KINASE; SERINE; THREONINE;

AMINO ACID SEQUENCE; AUTOPHOSPHORYLATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CENTROSOME; ENZYME REGULATION; ENZYME SUBSTRATE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL CYCLE; CENTROSOME; HUMANS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

INVERTEBRATA; MAMMALIA;

EID: 38149140880     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2007.07.017     Document Type: Review

References (111)

1. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
2. Hanks S.K., and Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9 (1995) 576-596
3. Johnson L.N., Noble M.E., and Owen D.J. Active and inactive protein kinases: structural basis for regulation. Cell 85 (1996) 149-158
4. Hergovich A., Stegert M.R., Schmitz D., and Hemmings B.A. NDR kinases regulate essential cell processes from yeast to humans. Nat. Rev., Mol. Cell Biol. 7 (2006) 253-264
5. Hergovich A., Lamla S., Nigg E.A., and Hemmings B.A. Centrosome-associated NDR kinase regulates centrosome duplication. Mol. Cell 25 (2007) 625-634
6. Stegert M.R., Tamaskovic R., Bichsel S.J., Hergovich A., and Hemmings B.A. Regulation of NDR2 protein kinase by multi-site phosphorylation and the S100B calcium-binding protein. J. Biol. Chem. 279 (2004) 23806-23812
7. Tamaskovic R., Bichsel S.J., Rogniaux H., Stegert M.R., and Hemmings B.A. Mechanism of Ca2+-mediated regulation of NDR protein kinase through autophosphorylation and phosphorylation by an upstream kinase. J. Biol. Chem. 278 (2003) 6710-6718
8. Bichsel S.J., Tamaskovic R., Stegert M.R., and Hemmings B.A. Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. J. Biol. Chem. 279 (2004) 35228-35235
9. Yang J., Cron P., Thompson V., Good V.M., Hess D., Hemmings B.A., and Barford D. Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation. Mol. Cell 9 (2002) 1227-1240
10. Millward T.A., Hess D., and Hemmings B.A. Ndr protein kinase is regulated by phosphorylation on two conserved sequence motifs. J. Biol. Chem. 274 (1999) 33847-33850
11. Stegert M.R., Hergovich A., Tamaskovic R., Bichsel S.J., and Hemmings B.A. Regulation of NDR protein kinase by hydrophobic motif phosphorylation mediated by the mammalian Ste20-like kinase MST3. Mol. Cell. Biol. 25 (2005) 11019-11029
12. Chan E.H., Nousiainen M., Chalamalasetty R.B., Schafer A., Nigg E.A., and Sillje H.H. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24 (2005) 2076-2086
13. Emoto K., Parrish J.Z., Jan L.Y., and Jan Y.N. The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance. Nature 443 (2006) 210-213
14. Lai Z.C., Wei X., Shimizu T., Ramos E., Rohrbaugh M., Nikolaidis N., Ho L.L., and Li Y. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120 (2005) 675-685
15. He Y., Emoto K., Fang X., Ren N., Tian X., Jan Y.N., and Adler P.N. Drosophila Mob family proteins interact with the related tricornered (Trc) and warts (Wts) kinases. Mol Biol. Cell 16 (2005) 4139-4152
16. Stavridi E.S., Harris K.G., Huyen Y., Bothos J., Verwoerd P.M., Stayrook S.E., Pavletich N.P., Jeffrey P.D., and Luca F.C. Crystal structure of a human Mob1 protein: toward understanding Mob-regulated cell cycle pathways. Structure 11 (2003) 1163-1170
17. Hergovich A., Bichsel S.J., and Hemmings B.A. Human NDR kinases are rapidly activated by MOB proteins through recruitment to the plasma membrane and phosphorylation. Mol. Cell. Biol. 25 (2005) 8259-8272
18. Hergovich A., Schmitz D., and Hemmings B.A. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem. Biophys. Res. Commun. 345 (2006) 50-58
19. Mrkobrada S., Boucher L., Ceccarelli D.F., Tyers M., and Sicheri F. Structural and functional analysis of Saccharomyces cerevisiae Mob1. J. Mol. Biol. 362 (2006) 430-440
20. Ponchon L., Dumas C., Kajava A.V., Fesquet D., and Padilla A. NMR solution structure of Mob1, a mitotic exit network protein and its interaction with an NDR kinase peptide. J. Mol. Biol. 337 (2004) 167-182
21. Bothos J., Tuttle R.L., Ottey M., Luca F.C., and Halazonetis T.D. Human LATS1 is a mitotic exit network kinase. Cancer Res. 65 (2005) 6568-6575
22. Hou M.C., Guertin D.A., and McCollum D. Initiation of cytokinesis is controlled through multiple modes of regulation of the Sid2p-Mob1p kinase complex. Mol. Cell. Biol. 24 (2004) 3262-3276
23. Harvey K., and Tapon N. The Salvador-Warts-Hippo pathway-an emerging tumour-suppressor network. Nat. Rev., Cancer 7 (2007) 182-191
24. Pan D. Hippo signaling in organ size control. Genes Dev. 21 (2007) 886-897
25. Wei X., Shimizu T., and Lai Z.C. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 26 (2007) 1772-1781
26. Colombani J., Polesello C., Josue F., and Tapon N. Dmp53 activates the Hippo pathway to promote cell death in response to DNA damage. Curr. Biol. 16 (2006) 1453-1458
27. Callus B.A., Verhagen A.M., and Vaux D.L. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 273 (2006) 4264-4276
28. Guo C., Tommasi S., Liu L., Yee J.K., Dammann R., and Pfeifer G.P. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr. Biol. 17 (2007) 700-705
29. Yabuta N., Okada N., Ito A., Hosomi T., Nishihara S., Sasayama Y., Fujimori A., Okuzaki D., Zhao H., Ikawa M., Okabe M., and Nojima H. Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282 (2007) 19259-19271
30. Overholtzer M., Zhang J., Smolen G.A., Muir B., Li W., Sgroi D.C., Deng C.X., Brugge J.S., and Haber D.A. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 12405-12410
31. Polesello C., Huelsmann S., Brown N.H., and Tapon N. The Drosophila RASSF homolog antagonizes the hippo pathway. Curr. Biol. 16 (2006) 2459-2465
32. Bardin A.J., and Amon A. Men and sin: what's the difference?. Nat. Rev., Mol. Cell Biol. 2 (2001) 815-826
33. Bosl W.J., and Li R. Mitotic-exit control as an evolved complex system. Cell 121 (2005) 325-333
34. Vazquez-Novelle M.D., Esteban V., Bueno A., and Sacristan M.P. Functional homology among human and fission yeast Cdc14 phosphatases. J. Biol. Chem. 280 (2005) 29144-29150
35. Walton F.J., Heitman J., and Idnurm A. Conserved elements of the RAM signaling pathway establish cell polarity in the basidiomycete Cryptococcus neoformans in a divergent fashion from other fungi. Mol. Biol. Cell 17 (2006) 3768-3780
36. Parrish J.Z., Emoto K., Jan L.Y., and Jan Y.N. Polycomb genes interact with the tumor suppressor genes hippo and warts in the maintenance of Drosophila sensory neuron dendrites. Genes Dev. 21 (2007) 956-972
37. Gallegos M.E., and Bargmann C.I. Mechanosensory neurite termination and tiling depend on SAX-2 and the SAX-1 kinase. Neuron 44 (2004) 239-249
38. St John M.A., Tao W., Fei X., Fukumoto R., Carcangiu M.L., Brownstein D.G., Parlow A.F., McGrath J., and Xu T. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat. Genet. 21 (1999) 182-186
39. Hisaoka M., Tanaka A., and Hashimoto H. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab. Invest. 82 (2002) 1427-1435
40. Jiang Z., Li X., Hu J., Zhou W., Jiang Y., Li G., and Lu D. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma. Neurosci. Res. 56 (2006) 450-458
41. Jimenez-Velasco A., Roman-Gomez J., Agirre X., Barrios M., Navarro G., Vazquez I., Prosper F., Torres A., and Heiniger A. Downregulation of the large tumor suppressor 2 (LATS2/KPM) gene is associated with poor prognosis in acute lymphoblastic leukemia. Leukemia 19 (2005) 2347-2350
42. Takahashi Y., Miyoshi Y., Takahata C., Irahara N., Taguchi T., Tamaki Y., and Noguchi S. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers. Clin. Cancer Res. 11 (2005) 1380-1385
43. Xia H., Qi H., Li Y., Pei J., Barton J., Blackstad M., Xu T., and Tao W. LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 21 (2002) 1233-1241
44. Li Y., Pei J., Xia H., Ke H., Wang H., and Tao W. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22 (2003) 4398-4405
45. McPherson J.P., Tamblyn L., Elia A., Migon E., Shehabeldin A., Matysiak-Zablocki E., Lemmers B., Salmena L., Hakem A., Fish J., Kassam F., Squire J., Bruneau B.G., Hande M.P., and Hakem R. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23 (2004) 3677-3688
46. Adeyinka A., Emberley E., Niu Y., Snell L., Murphy L.C., Sowter H., Wykoff C.C., Harris A.L., and Watson P.H. Analysis of gene expression in ductal carcinoma in situ of the breast. Clin. Cancer Res. 8 (2002) 3788-3795
47. Bhattacharjee A., Richards W.G., Staunton J., Li C., Monti S., Vasa P., Ladd C., Beheshti J., Bueno R., Gillette M., Loda M., Weber G., Mark E.J., Lander E.S., Wong W., Johnson B.E., Golub T.R., Sugarbaker D.J., and Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13790-13795
48. Garber M.E., Troyanskaya O.G., Schluens K., Petersen S., Thaesler Z., Pacyna-Gengelbach M., van de Rijn M., Rosen G.D., Perou C.M., Whyte R.I., Altman R.B., Brown P.O., Botstein D., and Petersen I. Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13784-13789
49. Lu K.H., Patterson A.P., Wang L., Marquez R.T., Atkinson E.N., Baggerly K.A., Ramoth L.R., Rosen D.G., Liu J., Hellstrom I., Smith D., Hartmann L., Fishman D., Berchuck A., Schmandt R., Whitaker R., Gershenson D.M., Mills G.B., and Bast Jr. R.C. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin. Cancer Res. 10 (2004) 3291-3300
50. Welsh J.B., Zarrinkar P.P., Sapinoso L.M., Kern S.G., Behling C.A., Monk B.J., Lockhart D.J., Burger R.A., and Hampton G.M. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 1176-1181
51. Korkola J.E., Houldsworth J., Chadalavada R.S., Olshen A.B., Dobrzynski D., Reuter V.E., Bosl G.J., and Chaganti R.S. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res. 66 (2006) 820-827
52. Sperger J.M., Chen X., Draper J.S., Antosiewicz J.E., Chon C.H., Jones S.B., Brooks J.D., Andrews P.W., Brown P.O., and Thomson J.A. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 13350-13355
53. Schaner M.E., Ross D.T., Ciaravino G., Sorlie T., Troyanskaya O., Diehn M., Wang Y.C., Duran G.E., Sikic T.L., Caldeira S., Skomedal H., Tu I.P., Hernandez-Boussard T., Johnson S.W., O'Dwyer P.J., Fero M.J., Kristensen G.B., Borresen-Dale A.L., Hastie T., Tibshirani R., van de Rijn M., Teng N.N., Longacre T.A., Botstein D., Brown P.O., and Sikic B.I. Gene expression patterns in ovarian carcinomas. Mol. Biol. Cell 14 (2003) 4376-4386
54. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., Iyer V., Jeffrey S.S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J.C., Lashkari D., Shalon D., Myers T.G., Weinstein J.N., Botstein D., and Brown P.O. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24 (2000) 227-235
55. Millward T.A., Heizmann C.W., Schafer B.W., and Hemmings B.A. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17 (1998) 5913-5922
56. Suzuki T., Shen H., Akagi K., Morse H.C., Malley J.D., Naiman D.Q., Jenkins N.A., and Copeland N.G. New genes involved in cancer identified by retroviral tagging. Nat. Genet. 32 (2002) 166-174
57. Lapointe J., Li C., Higgins J.P., van de Rijn M., Bair E., Montgomery K., Ferrari M., Egevad L., Rayford W., Bergerheim U., Ekman P., DeMarzo A.M., Tibshirani R., Botstein D., Brown P.O., Brooks J.D., and Pollack J.R. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 811-816
58. LaTulippe E., Satagopan J., Smith A., Scher H., Scardino P., Reuter V., and Gerald W.L. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 62 (2002) 4499-4506
59. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., Frierson Jr. H.F., and Hampton G.M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61 (2001) 5974-5978
60. Yu Y.P., Landsittel D., Jing L., Nelson J., Ren B., Liu L., McDonald C., Thomas R., Dhir R., Finkelstein S., Michalopoulos G., Becich M., and Luo J.H. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22 (2004) 2790-2799
61. Rowl B.D., and Peeper D.S. KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev., Cancer 6 (2006) 11-23
62. Yang X., Li D.M., Chen W., and Xu T. Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis. Oncogene 20 (2001) 6516-6523
63. Kuninaka S., Iida S.I., Hara T., Nomura M., Naoe H., Morisaki T., Nitta M., Arima Y., Mimori T., Yonehara S., and Saya H. Serine protease Omi/HtrA2 targets WARTS kinase to control cell proliferation. Oncogene 26 (2007) 2395-2406
64. Kuninaka S., Nomura M., Hirota T., Iida S., Hara T., Honda S., Kunitoku N., Sasayama T., Arima Y., Marumoto T., Koja K., Yonehara S., and Saya H. The tumor suppressor WARTS activates the Omi/HtrA2-dependent pathway of cell death. Oncogene 24 (2005) 5287-5298
65. Takahashi A., Ohtani N., Yamakoshi K., Iida S., Tahara H., Nakayama K., Nakayama K.I., Ide T., Saya H., and Hara E. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat. Cell Biol. 8 (2006) 1291-1297
66. Iida S., Hirota T., Morisaki T., Marumoto T., Hara T., Kuninaka S., Honda S., Kosai K., Kawasuji M., Pallas D.C., and Saya H. Tumor suppressor WARTS ensures genomic integrity by regulating both mitotic progression and G1 tetraploidy checkpoint function. Oncogene 23 (2004) 5266-5274
67. Yang X., Yu K., Hao Y., Li D.M., Stewart R., Insogna K.L., and Xu T. LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1. Nat. Cell Biol. 6 (2004) 609-617
68. Ke H., Pei J., Ni Z., Xia H., Qi H., Woods T., Kelekar A., and Tao W. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Exp. Cell Res. 298 (2004) 329-338
69. Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H., and Oren M. A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization. Genes Dev. 20 (2006) 2687-2700
70. Voorhoeve P.M., le Sage C., Schrier M., Gillis A.J., Stoop H., Nagel R., Liu Y.P., van Duijse J., Drost J., Griekspoor A., Zlotorynski E., Yabuta N., De Vita G., Nojima H., Looijenga L.H., and Agami R. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124 (2006) 1169-1181
71. Stork O., Zhdanov A., Kudersky A., Yoshikawa T., Obata K., and Pape H.C. Neuronal functions of the novel serine/threonine kinase Ndr2. J. Biol. Chem. 279 (2004) 45773-45781
72. Emoto K., He Y., Ye B., Grueber W.B., Adler P.N., Jan L.Y., and Jan Y.N. Control of dendritic branching and tiling by the Tricornered-kinase/Furry signaling pathway in Drosophila sensory neurons. Cell 119 (2004) 245-256
73. Bettencourt-Dias M., and Glover D.M. Centrosome biogenesis and function: centrosomics brings new understanding. Nat. Rev., Mol. Cell Biol. 8 (2007) 451-463
74. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev., Cancer 2 (2002) 815-825
75. Sluder G., and Nordberg J.J. The good, the bad and the ugly: the practical consequences of centrosome amplification. Curr. Opin. Cell Biol. 16 (2004) 49-54
76. Badano J.L., Teslovich T.M., and Katsanis N. The centrosome in human genetic disease. Nat. Rev., Genet. 6 (2005) 194-205
77. Christensen S.T., Pedersen L.B., Schneider L., and Satir P. Sensory cilia and integration of signal transduction in human health and disease. Traffic 8 (2007) 97-109
78. Hildebrandt F., and Otto E. Cilia and centrosomes: a unifying pathogenic concept for cystic kidney disease?. Nat. Rev., Genet. 6 (2005) 928-940
79. Leidel S., and Gonczy P. Centrosome duplication and nematodes: recent insights from an old relationship. Dev. Cell 9 (2005) 317-325
80. Bettencourt-Dias M., Rodrigues-Martins A., Carpenter L., Riparbelli M., Lehmann L., Gatt M.K., Carmo N., Balloux F., Callaini G., and Glover D.M. SAK/PLK4 is required for centriole duplication and flagella development. Curr. Biol. 15 (2005) 2199-2207
81. Habedanck R., Stierhof Y.D., Wilkinson C.J., and Nigg E.A. The Polo kinase Plk4 functions in centriole duplication. Nat. Cell Biol. 7 (2005) 1140-1146
82. Leidel S., Delattre M., Cerutti L., Baumer K., and Gonczy P. SAS-6 defines a protein family required for centrosome duplication in C. elegans and in human cells. Nat. Cell Biol. 7 (2005) 115-125
83. O'Connell K.F., Caron C., Kopish K.R., Hurd D.D., Kemphues K.J., Li Y., and White J.G. The C. elegans zyg-1 gene encodes a regulator of centrosome duplication with distinct maternal and paternal roles in the embryo. Cell 105 (2001) 547-558
84. Peel N., Stevens N.R., Basto R., and Raff J.W. Overexpressing centriole-replication proteins in vivo induces centriole overduplication and de novo formation. Curr. Biol. 17 (2007) 834-843
85. Pelletier L., O'Toole E., Schwager A., Hyman A.A., and Muller-Reichert T. Centriole assembly in Caenorhabditis elegans. Nature 444 (2006) 619-623
86. Rodrigues-Martins A., Riparbelli M., Callaini G., Glover D.M., and Bettencourt-Dias M. Revisiting the role of the mother centriole in centriole biogenesis. Science 316 (2007) 1046-1050
87. Cowan C.R., and Hyman A.A. Cyclin E-Cdk2 temporally regulates centrosome assembly and establishment of polarity in Caenorhabditis elegans embryos. Nat. Cell Biol. 8 (2006) 1441-1447
88. Duensing A., Liu Y., Tseng M., Malumbres M., Barbacid M., and Duensing S. Cyclin-dependent kinase 2 is dispensable for normal centrosome duplication but required for oncogene-induced centrosome overduplication. Oncogene 25 (2006) 2943-2949
89. Hinchcliffe E.H., Li C., Thompson E.A., Maller J.L., and Sluder G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283 (1999) 851-854
90. Lacey K.R., Jackson P.K., and Stearns T. Cyclin-dependent kinase control of centrosome duplication. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 2817-2822
91. Matsumoto Y., Hayashi K., and Nishida E. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells. Curr. Biol. 9 (1999) 429-432
92. Meraldi P., Lukas J., Fry A.M., Bartek J., and Nigg E.A. Centrosome duplication in mammalian somatic cells requires E2F and Cdk2-cyclin A. Nat. Cell Biol. 1 (1999) 88-93
93. Abe Y., Ohsugi M., Haraguchi K., Fujimoto J., and Yamamoto T. LATS2-Ajuba complex regulates gamma-tubulin recruitment to centrosomes and spindle organization during mitosis. FEBS Lett. 580 (2006) 782-788
94. Hirota T., Morisaki T., Nishiyama Y., Marumoto T., Tada K., Hara T., Masuko N., Inagaki M., Hatakeyama K., and Saya H. Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J. Cell Biol. 149 (2000) 1073-1086
95. Morisaki T., Hirota T., Iida S., Marumoto T., Hara T., Nishiyama Y., Kawasuzi M., Hiraoka T., Mimori T., Araki N., Izawa I., Inagaki M., and Saya H. WARTS tumor suppressor is phosphorylated by Cdc2/cyclin B at spindle poles during mitosis. FEBS Lett. 529 (2002) 319-324
96. Nishiyama Y., Hirota T., Morisaki T., Hara T., Marumoto T., Iida S., Makino K., Yamamoto H., Hiraoka T., Kitamura N., and Saya H. A human homolog of Drosophila warts tumor suppressor, h-warts, localized to mitotic apparatus and specifically phosphorylated during mitosis. FEBS Lett. 459 (1999) 159-165
97. Toji S., Yabuta N., Hosomi T., Nishihara S., Kobayashi T., Suzuki S., Tamai K., and Nojima H. The centrosomal protein Lats2 is a phosphorylation target of Aurora-A kinase. Genes Cells 9 (2004) 383-397
98. Doxsey S., McCollum D., and Theurkauf W. Centrosomes in cellular regulation. Annu. Rev. Cell Dev. Biol. 21 (2005) 411-434
99. Sluder G. Two-way traffic: centrosomes and the cell cycle. Nat. Rev., Mol. Cell Biol. 6 (2005) 743-748
100. Kramer A. Centrosome aberrations-hen or egg in cancer initiation and progression?. Leukemia 19 (2005) 1142-1144
101. Kramer A., Neben K., and Ho A.D. Centrosome aberrations in hematological malignancies. Cell Biol. Int. 29 (2005) 375-383
102. D'Assoro A.B., Lingle W.L., and Salisbury J.L. Centrosome amplification and the development of cancer. Oncogene 21 (2002) 6146-6153
103. Ko M.A., Rosario C.O., Hudson J.W., Kulkarni S., Pollett A., Dennis J.W., and Swallow C.J. Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis. Nat. Genet. 37 (2005) 883-888
104. Hudson J.W., Kozarova A., Cheung P., Macmillan J.C., Swallow C.J., Cross J.C., and Dennis J.W. Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr. Biol. 11 (2001) 441-446
105. Grisendi S., Bernardi R., Rossi M., Cheng K., Khandker L., Manova K., and Pandolfi P.P. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 437 (2005) 147-153
106. Okuda M., Horn H.F., Tarapore P., Tokuyama Y., Smulian A.G., Chan P.K., Knudsen E.S., Hofmann I.A., Snyder J.D., Bove K.E., and Fukasawa K. Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication. Cell 103 (2000) 127-140
107. Wang W., Budhu A., Forgues M., and Wang X.W. Temporal and spatial control of nucleophosmin by the Ran-Crm1 complex in centrosome duplication. Nat. Cell Biol. 7 (2005) 823-830
108. Boveri T. The Origin of Malignant Tumors (1914), Williams and Wilkins, Baltimore, Maryland
109. Naula C., Parsons M., and Mottram J.C. Protein kinases as drug targets in trypanosomes and Leishmania. Biochim. Biophys. Acta 1754 (2005) 151-159
110. Garcia-Salcedo J.A., Nolan D.P., Gijon P., Gomez-Rodriguez J., and Pays E. A protein kinase specifically associated with proliferative forms of Trypanosoma brucei is functionally related to a yeast kinase involved in the co-ordination of cell shape and division. Mol. Microbiol. 45 (2002) 307-319
111. Hammarton T.C., Lillico S.G., Welburn S.C., and Mottram J.C. Trypanosoma brucei MOB1 is required for accurate and efficient cytokinesis but not for exit from mitosis. Mol. Microbiol. 56 (2005) 104-116